SCHEMBL11022041

SCHEMBL11022041

CCC(=O)Nc1cnoc1C

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.53
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 6/20 0.40
HPGD P15428 3/20 0.40
PKM P14618 2/20 0.40
SMN1; SMN2 Q16637 5/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TP53 P04637 3/20 0.39
HTT P42858 2/20 0.38
MAPT P10636 2/20 0.38
MITF O75030 1/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4060937 0.81 CSF1R (0.58) CSF1RALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL11016941 0.79 CSF1R (0.57) CSF1RALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL27534143 0.79 CSF1R (0.47) CSF1RALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL27534146 0.79 CSF1R (0.47) CSF1RALDH1A1KDM4EHPGDPKM
SCHEMBL6105948 0.74 CSF1R (0.51) CSF1RSMN1; SMN2RAB9ANPC1HSD17B10
SCHEMBL26790051 0.72 P2RX7 (0.39)
SCHEMBL26792058 0.70 PKM (0.49) ALDH1A1KDM4EHPGDPKMSMN1; SMN2
SCHEMBL26789538 0.70 NPSR1 (0.47) ALDH1A1KDM4EHPGDPKMSMN1; SMN2
Hydrochloric Acid SCHEMBL1448612 0.69 CSF1R (0.39) CSF1RALDH1A1HSD17B10
SCHEMBL17251487 0.68 LMNA (0.49) ALDH1A1KDM4EHPGDPKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220247-A1 LRRK2 INHIBITORS INTERLINE THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
CN-1649863-A 4- (imidazol-5-yl) -2- (4-sulfoanilino) pyrimidine derivatives having CDK inhibitory activity ASTRAZENECA AB (SE) 2005-08-03 CN disclosed
EP-0156644-A1 Process and intermediates for 4-acetylimidazoles PFIZER INC. (US) 1985-10-02 EP disclosed